We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > FluGen

News List

FluGen, Bharat Biotech and UW–Madison partner on Covid-19 vaccine pharmaceutical-technology
April 06, 2020
Vaccine development companies FluGen and Bharat Biotech have partnered with the University of Wisconsin–Madison (UWMadison) to develop and evaluate a Covid-19 vaccine candidate, CoroFlu.
FluGen’s broadly protective flu vaccine clears phase 1 fiercepharma
December 04, 2018
Every year, scientists have to choose which strains of flu virus to include in the coming season's flu shots, and when the vaccine strains don't match the circulating strains, vaccine effectiveness can be much lower.
FluGen Awarded $14.4 million by the DoD to Test Universal Flu Vaccine Against Mismatched Strains americanpharmaceuticacreview
October 19, 2017
Under the three-year award, FluGen will conduct two challenge-studies with RedeeFlu. In these studies, half of the participants will be vaccinated and half will receive a placebo but all will subsequently be infected with an influenza virus.